United States · FDA National Drug Code directory
JAYTHARI Oral Suspension
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-2131_2ae3f985-ae3a-4d9a-98e3-d5d3d50c0490
- Product NDC
- 70710-2131
- Form
- SUSPENSION
- Composition / generic term
- Deflazacort
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251120
- Source listing expiry
- 20271231
Source-listed ingredients
- DEFLAZACORT — 22.75 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (70710-2131-3) / 13 mL in 1 BOTTLE · 70710-2131-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →